Journal
RENAL REPLACEMENT THERAPY
Volume 7, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s41100-021-00365-5
Keywords
Shared decision making; Advance care planning; Chronic kidney disease; End-stage kidney disease; Dialysis; Fogo
Categories
Ask authors/readers for more resources
The JSDT revised the proposal in 2020 to guide healthcare teams in providing the best healthcare management and care respecting the patient's will through advance care planning and shared decision making. This includes conservative kidney management for all end-stage kidney disease patients, regardless of terminal stage or dementia. The proposal is consensus-based rather than evidence-based, which means healthcare teams may not be legally exempt if implementing the policies results in the patient's death.
Background In Japan, forgoing life-sustaining treatment to respect the will of patients at the terminal stage is not stipulated by law. According to the Guidelines for the Decision-Making Process in Terminal-Stage Healthcare published by the Ministry of Health, Labor and Welfare in 2007, the Japanese Society for Dialysis Therapy (JSDT) developed a proposal that was limited to patients at the terminal stage and did not explicitly cover patients with dementia. This proposal for the shared decision-making process regarding the initiation and continuation of maintenance hemodialysis was published in 2014. Methods and results In response to changes in social conditions, the JSDT revised the proposal in 2020 to provide guidance for the process by which the healthcare team can provide the best healthcare management and care with respect to the patient's will through advance care planning and shared decision making. For all patients with end-stage kidney disease, including those at the nonterminal stage and those with dementia, the decision-making process includes conservative kidney management. Conclusions The proposal is based on consensus rather than evidence-based clinical practice guidelines. The healthcare team is therefore not guaranteed to be legally exempt if the patient dies after the policies in the proposal are implemented and must respond appropriately at the discretion of each institution.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available